Pixelgen Technologies, a Stockholm-based company that claims to have developed the first high-throughput platform for #mapping molecular #cell architecture, has...

Pixelgen Technologies, a Stockholm-based company that claims to have developed the first high-throughput platform for #mapping molecular #cell architecture, has closed a €13.26 million Series B #funding round. 🇸🇪 🔬 💊

https://t.co/9dtHYXb7fh